Aug. 19 at 4:47 PM
In this episode of WTR Healthcare Happenings, Dr. Marvin Hausman, Co-Founder & CSO of Ludwig Enterprises Inc. (OTC: LUDG), shares how the company’s cheek-swabbing mRNA genomic platform could transform diagnostics.
🔹 Early detection of chronic inflammatory-driven diseases like cancer
🔹 Breakthrough potential in personalized medicine
🔹 Proprietary, innovative mRNA technology platform
Tune in with WTR's Tim Gerdeman & Robert Sassoon to hear why Dr. Hausman believes this platform could be a revolutionary tool for the future of healthcare.
Apple: https://podcasts.apple.com/us/podcast/ludwigs-dr-marvin-hausman-on-why-its-cheek-swabbing/id1795488592?i=1000722644625
Spotify: https://open.spotify.com/episode/3dNMrNLbl3tCQDiNq0QS4O?si=27934f84f6134e4b
Website: https://www.watertowerresearch.com/media-detail/2316/Media
Others: https://pod.link/1693448305
#WTRHealthcareHappenings #LudwigEnterprises
$LUDG #mRNA #Genomics #Diagnostics #PersonalizedMedicine #SmallCap #Stocks #Investing #WTRSpotlight